📖

Ubiquitin-Proteasome System Therapeutic Companies for Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-companies-pd-ubiquitin-proteasome-s
Related Entities
companies-pd-ubiquitin-proteasome-system-therapeutic-companies
Metadata
slugcompanies-pd-ubiquitin-proteasome-system-therapeutic-companies
entity_typecompany
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (388)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
related🧫Tau ASO Therapy70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
related🧫Tau ASO Therapy70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
see_also📖ABCD3 Gene60%
see_also📖ACE Gene60%
see_also📖ACTB Gene60%
see_also📖APEX2 Gene60%
see_also📖BAG260%
see_also📖CHMP1B — Charged Multivesicular Body Protein 1B60%
see_also📖EPHB2 Gene60%
see_also📖GLUL — Glutamine Synthetase60%
see_also📖kdm3a60%
see_also📖NUP98 — Nucleoporin 9860%
see_also📖PJA1 Gene — Praja1 RING Finger E3 Ubiquitin Ligase60%
see_also📖SPG20 Gene60%
see_also📖USP14 Gene60%
see_also📖XRCC6 Gene60%
see_also📖ZNF7 - Zinc Finger Protein 760%
see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%
see_also📖Mitophagy Receptor Pathway in Neurodegeneration60%
see_also📖BAG2 Protein60%
see_also📖HERC2 Gene60%
see_also📖RNF2060%
see_also📖UFM1 — Ubiquitin-like Modifier 160%
see_also📖YWHAB Gene60%
see_also📖NDP52 Gene60%
see_also📖SQSTM1 — Sequestosome 1 (p62)60%
see_also📖Actin Cytoskeleton Dynamics in Neurodegeneration60%
see_also📖herc360%
see_also📖HERC6 — HECT and RLD Domain Containing E3 Ubiquitin Protein 60%
see_also📖SENP2 — SUMO Specific Peptidase 260%
see_also📖UBE2I — SUMO-Conjugating Enzyme60%
see_also📖JARID260%
see_also📖slc44a260%
see_also📖UBR5 - Ubiquitin-Protein Ligase E3 Component N-Recognin 560%
see_also📖XPO1 Gene60%
see_also📖DDX6 Gene60%
see_also📖FBXO45 - F-Box Protein 4560%
see_also📖NBR1 Gene60%
see_also📖OPTN — Optineurin60%
see_also📖PPP1R15B60%
see_also📖RPN2 Gene60%
see_also📖SNCA — Alpha-Synuclein60%
see_also📖UBR4 — Ubiquitin Protein Ligase E3 Component N-Recognin 460%
see_also📖VPS13D Gene60%
see_also📖VPS13D Protein60%
see_also📖proteins-vps13d-protein60%
see_also📖PRKN — Parkin RBR E3 Ubiquitin Protein Ligase60%
see_also📖BECN1 Gene60%
see_also📖ULK1 — UNC-51 Like Kinase 160%
see_also📖PINK1 (PTEN-Induced Kinase 1)60%
see_also📖Parkin (PARK2)60%
see_also📖PARKIN Gene60%
see_also📖ABIN1 (TNIP1) Gene60%
see_also📖ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Member 460%
see_also📖MARK2 Gene60%
see_also📖MLKL Gene60%
see_also📖OTUD3 — OTU Deubiquitinase 360%
see_also📖PELI1 Gene60%
see_also📖PEX1 Gene - Peroxisome Biogenesis Factor 160%
see_also📖RAB11A — Ras-Related Protein Rab-11A60%
see_also📖RAB1A — Ras-Related Protein Rab-1A60%
see_also📖ACLY Inhibition Rescues Alpha-Synuclein Autophagy60%
see_also📖Protein Homeostasis in Neurodegeneration60%
see_also📖Protein Quality Control in Neurodegeneration60%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro55%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin50%
mentions🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
mentions🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%
mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%
mentions🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%
mentions🧪Circadian-Synchronized Proteostasis Enhancement50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪VCP-Mediated Autophagy Enhancement50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪Cryptic Exon Silencing Restoration50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Lysosomal Membrane Repair Enhancement50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪Flotillin-1 Stabilization Compounds50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪Digital Twin-Guided Metabolic Reprogramming50%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%
mentions🧪Microbial Inflammasome Priming Prevention50%
mentions🧪Nucleolar Stress Response Normalization50%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪RNA Granule Nucleation Site Modulation50%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar50%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%
mentions🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar40%
related🧪Mitochondrial-Lysosomal Contact Site Engineering40%
related🧪Circadian-Synchronized Proteostasis Enhancement40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪HSP90-Tau Disaggregation Complex Enhancement40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%
related🧪VCP-Mediated Autophagy Enhancement40%
related🧪Arginine Methylation Enhancement Therapy40%
related🧪SASP-Mediated Cholinergic Synapse Disruption40%
related🧪Enteric Nervous System Prion-Like Propagation Blockade40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪Cryptic Exon Silencing Restoration40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
related🧪Heat Shock Protein 70 Disaggregase Amplification40%
related🧪Autophagosome Maturation Checkpoint Control40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🧪PARP1 Inhibition Therapy40%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪Lysosomal Membrane Repair Enhancement40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
related🧪Stress Granule Phase Separation Modulators40%
related🧪Flotillin-1 Stabilization Compounds40%
related🧪HDAC3-Selective Inhibition for Clock Reset40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Transcriptional Autophagy-Lysosome Coupling40%
related🧪Digital Twin-Guided Metabolic Reprogramming40%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪R-Loop Resolution Enhancement Therapy40%
related🧪Competitive APOE4 Domain Stabilization Peptides40%
related🧪Epigenetic Memory Erasure via TET2 Activation40%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%
related🧪Microbial Inflammasome Priming Prevention40%
related🧪Nucleolar Stress Response Normalization40%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%
related🧪RNA Granule Nucleation Site Modulation40%
mentions🔬What are the mechanisms underlying selective vulnerability o35%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t35%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%
mentions🔬What are the mechanisms underlying blood-brain barrier trans35%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross35%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa35%
mentions🔬What are the mechanisms underlying digital biomarkers and ai35%
mentions🔬What are the mechanisms underlying senolytic therapy for age35%
mentions🔬What are the mechanisms underlying neuroinflammation resolut35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying protein aggregation cross35%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli35%
mentions🔬What are the mechanisms underlying rna binding protein dysre35%
mentions🔬What are the mechanisms underlying synaptic pruning by micro35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%
mentions🔬What gene expression changes in the aging mouse brain predic35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc35%
mentions🔬Investigate prion-like spreading of tau pathology through co35%
related🔬What are the mechanisms underlying selective vulnerability o30%